Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies

作者：Dong-fang Shang, Wen-qian Xu, Qing Zhao, Chenlu Zhao, Siying Wang, Yongli Han, Hao Li, Minghao Liu, Wenxia Zhao · 发表于：Pharmacological Research · 年份：2025 · DOI：10.1016/j.phrs.2025.107754 · 被引用次数：8 · 研究领域：Inflammasome and immune disorders、Liver Disease Diagnosis and Treatment、Gout, Hyperuricemia, Uric Acid

Pyroptosis is a distinct form of cell death that plays a critical role in intensifying inflammatory responses. It primarily occurs via the classical pathway, non-classical pathway, caspase-3/6/7/8/9-mediated pathways, and granzyme-mediated pathways. Key effector proteins involved in the pyroptosis process include gasdermin family proteins and pannexin-1 protein. Pyroptosis is intricately linked to the onset and progression of non-alcoholic steatohepatitis (NASH). During the development of NASH, factors such as pyroptosis, innate immunity, lipotoxicity, endoplasmic reticulum stress, and gut microbiota imbalance interact and interweave, collectively driving disease progression. This review analyzes the molecular mechanisms of pyroptosis and its role in the pathogenesis of NASH. Furthermore, it explores potential diagnostic and therapeutic strategies targeting pyroptosis, offering new avenues for improving the diagnosis and treatment of NASH.